Literature DB >> 33120425

Lysosomal sulfatases: a growing family.

Torben Lübke1, Markus Damme2.   

Abstract

Sulfatases constitute a family of enzymes that specifically act in the hydrolytic degradation of sulfated metabolites by removing sulfate monoesters from various substrates, particularly glycolipids and glycosaminoglycans. A common essential feature of all known eukaryotic sulfatases is the posttranslational modification of a critical cysteine residue in their active site by oxidation to formylglycine (FGly), which is mediated by the FGly-generating enzyme in the endoplasmic reticulum and is indispensable for catalytic activity. The majority of the so far described sulfatases localize intracellularly to lysosomes, where they act in different catabolic pathways. Mutations in genes coding for lysosomal sulfatases lead to an accumulation of the sulfated substrates in lysosomes, resulting in impaired cellular function and multisystemic disorders presenting as lysosomal storage diseases, which also cover the mucopolysaccharidoses and metachromatic leukodystrophy. Bioinformatics analysis of the eukaryotic genomes revealed, besides the well described and long known disease-associated sulfatases, additional genes coding for putative enzymes with sulfatases activity, including arylsulfatase G as well as the arylsulfatases H, I, J and K, respectively. In this article, we review current knowledge about lysosomal sulfatases with a special focus on the just recently characterized family members arylsulfatase G and arylsulfatase K.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  formyl glycine-generating enzyme; glycosaminoglycans; lysosomal storage disease; lysosomes; mucopolysaccharidosis; sulfatase

Year:  2020        PMID: 33120425     DOI: 10.1042/BCJ20200586

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Mobility shift-based electrophoresis coupled with fluorescent detection enables real-time enzyme analysis of carbohydrate sulfatase activity.

Authors:  Dominic P Byrne; James A London; Patrick A Eyers; Edwin A Yates; Alan Cartmell
Journal:  Biochem J       Date:  2021-02-26       Impact factor: 3.857

2.  Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.

Authors:  Yiming Shen; Zhengyu Wei; Chongchang Zhou; Jiangping Song; Jianing Wang; Jiada Wang; Linrong Wu; Shenzhe Fang; Zhisen Shen
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

3.  Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency.

Authors:  Sarah Verheyen; Jasmin Blatterer; Michael R Speicher; Gandham SriLakshmi Bhavani; Geert-Jan Boons; Mai-Britt Ilse; Dominik Andrae; Jens Sproß; Frédéric Maxime Vaz; Susanne G Kircher; Laura Posch-Pertl; Daniela Baumgartner; Torben Lübke; Hitesh Shah; Ali Al Kaissi; Katta M Girisha; Barbara Plecko
Journal:  J Med Genet       Date:  2021-12-16       Impact factor: 5.941

4.  Differential expression of CD11c defines two types of tissue-resident macrophages with different origins in steady-state salivary glands.

Authors:  Lu Lu; Toshinobu Kuroishi; Yukinori Tanaka; Mutsumi Furukawa; Tomonori Nochi; Shunji Sugawara
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

5.  Forming 4-Methylcatechol as the Dominant Bioavailable Metabolite of Intraruminal Rutin Inhibits p-Cresol Production in Dairy Cows.

Authors:  Yue Guo; Wanda J Weber; Dan Yao; Luciano Caixeta; Noah P Zimmerman; Jesse Thompson; Elliot Block; Thomas G Rehberger; Brian A Crooker; Chi Chen
Journal:  Metabolites       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.